Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Vipergen Establishes Research Partnership with PhoreMost Focused on DNA Encoded Library (DEL)-Based Drug Discovery


COPENHAGEN, Denmark, Sept. 14, 2021 /PRNewswire/ -- Vipergen, a leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies, announced today the signing of a multi-target drug discovery agreement with PhoreMost. Under the terms of the agreement, Vipergen will apply its high-fidelity DEL technology platforms to identify novel small-molecule compounds that bind to selected PhoreMost protein targets. PhoreMost will select hits for development into novel therapeutics for oncology. PhoreMost will retain exclusive rights to globally commercialize any products resulting from the collaboration. Financial details of the agreement were not disclosed.

"Applying Vipergen's suite of leading technologies for DNA-encoded library synthesis and screening, we aim to optimize our success rate for discovering novel, high-quality small drug molecules for several oncology targets that were previously considered undruggable," said Rich Boyce, Vice President of Drug Discovery at PhoreMost. "We look forward to collaborating with the Vipergen team in our mission to deliver a diverse range of more effective and safe therapies for cancer patients."

"We are delighted to partner with PhoreMost in its unique mission to develop a pipeline of transformative new therapies for cancer patients by identifying novel drug molecules for binding sites that have eluded conventional target discovery," said Nils Hansen, PhD, Chief Executive Officer of Vipergen. "In particular, Vipergen's newest platform?which enables screening DNA-encoded small-molecule libraries inside living cells, under physiologically relevant conditions?significantly expands our ability to discover novel small molecules against challenging targets."

About Vipergen ApS
Vipergen is a world-leading provider of small-molecule drug discovery services based on DNA-encoded library (DEL) technologies and is the first and only company capable of screening DELs inside a living cell. Vipergen provides its proprietary suite of leading-edge DEL technologies through funded discovery partnerships with leading pharmaceutical and biotechnology companies, including top pharmaceutical companies in the U.S., EU, and Japan. For more details about Vipergen and the YoctoReactor® (yR), Binder Trap Enrichment® (BTE), and Cellular Binder Trap Enrichment® (cBTE) drug discovery technology platforms, please visit www.vipergen.com.

Contact:
Mary Moynihan
M2Friend Biocommunications
+1 (802) 951-9600
mary@m2friend.com

SOURCE Vipergen


These press releases may also interest you

at 08:53
Safecor Health, the market leader of pharmaceutical unit-dose packaging services for hospitals and health systems owned by Vesey Street Capital Partners, LLC ("VSCP"), a New York-based lower middle-market healthcare services private equity firm,...

at 08:52
Orbit Coffee is an Italian brand that recently crossed the pond into the U.S. market. While there is no end to the number of energy drinks available in the U.S. at this point, Orbit Coffee offers a new take on the concept of an energy "drink."...

at 08:50
Credence MedSystems, Inc. announced today that it has formed a strategic collaboration with Phillips-Medisize, a Molex company, a global leader in the design and manufacturing of solutions for the pharmaceutical drug delivery market. The strategic...

at 08:50
WorkWell, the experts in preventing and treating sprains, strains, and back pain, today announced its Managed Onsite PT Clinics to prevent and treat workplace injuries onsite quickly and cost-effectively. ...

at 08:50
MEDiSTRAVA, the global medical division of Huntsworth, and Sorcero, leaders in AI-Powered Language Intelligence, today unveiled a new partnership to significantly improve the ability of life science companies to extract, interpret, and action...

at 08:47
At the request of the National Spine Health Foundation (NSHF), the United States Congress has formally recognized the month of October as Spine Health Awareness Month to bring attention to an issue impacting 100 million Americans each year....



News published on 14 september 2021 at 08:00 and distributed by: